Cosmos Health EBITDA vs. Return On Equity
| COSM Stock | USD 0.77 0.02 2.53% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -8 M | Current Value -7.6 M | Quarterly Volatility 4.3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.0774 | 0.0815 |
|
|
For Cosmos Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cosmos Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cosmos Health utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cosmos Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cosmos Health over time as well as its relative position and ranking within its peers.
Cosmos |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cosmos Health. If investors know Cosmos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cosmos Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.45) | Revenue Per Share 3.733 | Quarterly Revenue Growth 0.068 | Return On Assets (0.20) | Return On Equity (0.57) |
The market value of Cosmos Health is measured differently than its book value, which is the value of Cosmos that is recorded on the company's balance sheet. Investors also form their own opinion of Cosmos Health's value that differs from its market value or its book value, called intrinsic value, which is Cosmos Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cosmos Health's market value can be influenced by many factors that don't directly affect Cosmos Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cosmos Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cosmos Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cosmos Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cosmos Health Return On Equity vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Cosmos Health's current stock value. Our valuation model uses many indicators to compare Cosmos Health value to that of its competitors to determine the firm's financial worth. Cosmos Health is rated below average in ebitda category among its peers. It is rated below average in return on equity category among its peers . Cosmos Health reported last year EBITDA of (8.01 Million). Comparative valuation analysis is a catch-all technique that is used if you cannot value Cosmos Health by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Cosmos Return On Equity vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Cosmos Health |
| = | (19.9 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Cosmos Health |
| = | -0.57 |
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Cosmos Return On Equity Comparison
Cosmos Health is currently under evaluation in return on equity category among its peers.
Cosmos Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Cosmos Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cosmos Health will eventually generate negative long term returns. The profitability progress is the general direction of Cosmos Health's change in net profit over the period of time. It can combine multiple indicators of Cosmos Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -1.3 M | -1.4 M | |
| Operating Income | -21.8 M | -20.7 M | |
| Income Before Tax | -18.5 M | -17.6 M | |
| Total Other Income Expense Net | 3.5 M | 3.7 M | |
| Net Loss | -18.5 M | -17.6 M | |
| Income Tax Expense | 891.3 K | 935.9 K | |
| Net Loss | -18.5 M | -17.6 M | |
| Net Loss | -14 M | -13.3 M | |
| Net Interest Income | -203.6 K | -213.8 K | |
| Interest Income | 662.9 K | 696 K | |
| Change To Netincome | 6.9 M | 7.2 M | |
| Net Loss | (1.55) | (1.63) | |
| Income Quality | 0.84 | 0.89 | |
| Net Income Per E B T | 0.95 | 0.76 |
Cosmos Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Cosmos Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cosmos Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cosmos Health's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Cosmos Health without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Competition Analyzer Now
Competition AnalyzerAnalyze and compare many basic indicators for a group of related or unrelated entities |
| All Next | Launch Module |
Use Investing Themes to Complement your Cosmos Health position
In addition to having Cosmos Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Materials ETFs Thematic Idea Now
Materials ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Materials ETFs theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Materials ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. To learn how to invest in Cosmos Stock, please use our How to Invest in Cosmos Health guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
To fully project Cosmos Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cosmos Health at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cosmos Health's income statement, its balance sheet, and the statement of cash flows.